Paper Details

  1. Home
  2. Paper Details

Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors.

Author: CatanzaroLinda M, DicenzoRobert, ForrestAlan, MaQing, MorseGene D, OkusanyaOlanrewaju O, SlishJudianne C, SmithPatrick F

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review provides an updated summary of pharmacokinetic interactions with non-nucleoside reverse transcriptase inhibitors (NNRTIs) used in HIV Type 1 treatment. NNRTIs are metabolized by the cytochrome P450 (CYP) system, making them prone to significant drug interactions with other antiretrovirals and concurrent medications.
Paper Details　
Original Abstract of the Article :
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a diverse group of compounds that inhibit HIV Type 1 reverse transcriptase. Although possessing a common mechanism of action, the approved NNRTIs, delavirdine, efavirenz and nevirapine, differ in structural and pharmacokinetic characterist...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/17425255.1.3.473

データ提供：米国国立医学図書館（NLM）

Navigating the Labyrinth of Drug Interactions: A Guide to Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

This research delves into the complex world of [pharmacokinetic drug interactions], particularly those involving [non-nucleoside reverse transcriptase inhibitors (NNRTIs)], a class of drugs used to treat [HIV infection]. The study investigates the various ways in which NNRTIs interact with other medications, highlighting the crucial importance of understanding these interactions for effective treatment of [HIV]. The research provides valuable guidance for clinicians seeking to optimize treatment regimens for patients with [HIV] infection.

NNRTIs: Understanding the Complexity of Drug Interactions

The study found that [NNRTIs] can interact with a variety of other medications, either by inhibiting or inducing the activity of [drug-metabolizing CYP enzymes]. This means that the effectiveness of NNRTIs and other medications can be significantly altered when used together. This research emphasizes the need for careful monitoring and adjustments to treatment regimens to ensure optimal outcomes for patients.

The Importance of Precision in Drug Therapy: A Desert of Possibilities

This research highlights the complexity of drug interactions, particularly those involving [NNRTIs]. It underscores the need for individualized approaches to drug therapy, taking into account the specific needs of each patient. It's like navigating a vast desert landscape – each journey requires careful planning and attention to detail to ensure successful navigation and avoid potential pitfalls.

Dr.Camel's Conclusion

This study underscores the importance of understanding pharmacokinetic drug interactions, particularly those involving NNRTIs. The research highlights the need for careful monitoring and adjustments to treatment regimens to ensure optimal outcomes for patients with HIV. By understanding the complexities of these interactions, we can better navigate the vast desert of drug therapy and provide the best possible care for our patients.

Date :
  1. Date Completed 2006-08-29
  2. Date Revised 2019-11-10
Further Info :

Pubmed ID

16863456

DOI: Digital Object Identifier

10.1517/17425255.1.3.473

Related Literature

Article Analysis
・Effects of delavirdine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.